APC and neoplasm: Injection of Apc+/Min-FCCC mice with a combination of KISIMA-Mash2 vaccine and anti-PD-1 induced the infiltration of CD3+ T lymphocytes into colon adenomas, indicating the treatment regimen successfully mobilized immune cells into the tumor microenvironment.